Petelytska L, et al. Vasodilation reduces the risk of new onset of interstitial lung disease in systemic sclerosis: an association study from the EUSTAR database. Presented at EULAR 2025; OP0334.

Ascites and hepatorenal syndrome In advanced cirrhosis, splanchnic arterial vasodilation promoted by portal hypertension is pronounced and leads to the impairment of systemic and splanchnic ...

Abdelwahed, A. H., et al. (2024) Effects of Transjugular Intrahepatic Portosystemic Shunt on Renal and Pulmonary Function in Hepatic Decompensation with and without Hepatorenal and Hepatopulmonary ...

HRS and HPS represent the most severe outcomes of cirrhosis, associated with systemic vasodilation driven by elevated levels of vasodilators like nitric oxide (NO).